Cleveland Scene: Man freed by UC OIP waits for new trial
Isaiah Washington, who walked free in May with the help of the Ohio Innocence Project at the University of Cincinnati College of Law after serving nearly 46 years in prison for a crime he did not commit, continues to await his day in court. The Cleveland Scene reports that the Eighth District Court of Appeals denied Cuyahoga County’s motion to seek an appeal of the order granting Andrews a new trial.
Andrews, now 82, was convicted in 1975 of the murder of his newlywed wife, Regina Andrews. He walked free on May 6 after a team of UC faculty, attorneys and students discovered evidence that strongly implicated another man committed the murder, but that evidence had been unlawfully suppressed from Andrews’ defense for 45 years.
A judge granted Andrews’ request for a new trial, which prosecutors oppose. A new trial date has not yet been set. Andrews is currently on house arrest and GPS monitoring. His OIP attorneys have filed a motion to have those restrictions lifted in advance of a new trial. The judge in his case has not yet ruled on that motion.
Read the full story here.
Featured image at top: Brian Howe and Isaiah Andrews after Andrews' release on Wednesday, May 6, 2020. Photo provided by Mark Godsey
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.